Long-term outcomes of paclitaxel-coated balloons for non-malignant ureteral strictures.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
May 2022
Historique:
received: 29 10 2021
accepted: 28 01 2022
pubmed: 6 3 2022
medline: 12 5 2022
entrez: 5 3 2022
Statut: ppublish

Résumé

To evaluate the clinical efficacy and safety of drug-coated balloon (DCB) ureteroplasty for the management of non-malignant ureteral strictures. A prospective "off-label" monocentric single-arm pilot study investigating the safety and efficacy of drug-coated balloon (DCB) (Lutonix Mean lesion length was 40 ± 28.5 mm. Mean time follow up was 36 months ± 10.46 months. Strictures were located at upper ureteric (12%), lower ureteric (32%), ureterovesical anastomosis (4%) and uretero-enteric anastomosis (52%) levels. The overall radiological success at 1-year follow-up was 88% (22/25 patients). In 56% patients (14/25 patients with primary patency) the nephrostomy catheter was removed 21 days following a single DCB procedure. In 32% (8/25 patients) an additional dilatation sessions were required for maintaining the ureteral patency. The overall failure rate at 1-year follow-up was 12% (3/25 patients). Only one case of febrile urinary tract infection in a female patient (acute pyelonephritis) was encountered after the first dilatation. Paclitaxel-coated balloon ureteroplasty proved to be safe and effective for the treatment of non-malignant ureteral strictures. Larger studies are warranted to validate these promising initial results.

Identifiants

pubmed: 35246705
doi: 10.1007/s00345-022-03952-1
pii: 10.1007/s00345-022-03952-1
doi:

Substances chimiques

Paclitaxel P88XT4IS4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1231-1238

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Tyritzis SI, Wiklund NP (2015) Ureteral strictures revisited…trying to see the light at the end of the tunnel: a comprehensive review. J Endourol 29(2):124–136. https://doi.org/10.1089/end.2014.0522
doi: 10.1089/end.2014.0522 pubmed: 25100183
Wolf JS Jr, Elashry OM, Clayman RV (1997) Long-term results of endoureterotomy for benign ureteral and ureteroenteric strictures. J Urol 158(3 Pt 1):759–764. https://doi.org/10.1097/00005392-199709000-00016
doi: 10.1097/00005392-199709000-00016 pubmed: 9258075
Koukouras D, Petsas T, Liatsikos E, Kallidonis P, Sdralis EK, Adonakis G, Panagopoulos C, Al-Aown A, Decavalas G, Perimenis P, Siablis D, Karnabatidis D (2010) Percutaneous minimally invasive management of iatrogenic ureteral injuries. J Endourol 24(12):1921–1927
doi: 10.1089/end.2010.0153
Stolzenburg JU, Rai BP, Do M, Dietel A, Liatsikos E, Ganzer R, Qazi H, Meneses AD, Kallidonis P (2016) Robot-assisted technique for Boari flap ureteric reimplantation: replicating the techniques of open surgery in robotics. BJU Int 118(3):482–484. https://doi.org/10.1111/bju.13502
doi: 10.1111/bju.13502 pubmed: 27103101
Uflacker A, Sheeran D, Khaja M, Patrie J, Elias G, Saad W (2015) Outcomes of percutaneous management of anastomotic ureteral strictures in renal transplantation: chronic nephroureteral stent placement with and without balloon dilatation. Cardiovasc Intervent Radiol 38(3):693–701
doi: 10.1007/s00270-014-0952-8
Lu C, Zhang W, Peng Y, Li L, Gao X, Liu M, Fang Z, Wang Z, Ming S, Dong H, Shen R, Xie F, Sun Y, Gao X (2019) Endoscopic balloon dilatation in the treatment of benign ureteral strictures: a meta-analysis and systematic review. J Endourol 33(4):255–262. https://doi.org/10.1089/end.2018.0797
doi: 10.1089/end.2018.0797 pubmed: 30628477
Schmeller N, Leitl F, Arnholdt H (1992) Histology of ureter after unsuccessful endoscopic intubated incision. J Urol 147(2):450–452
doi: 10.1016/S0022-5347(17)37267-1
Baskin LS, Constantinescu SC, Howard PS, McAninch JW, Ewalt DH, Duckett JW, Snyder HM, Macarak EJ (1993) Biochemical characterization and quantitation of the collagenous components of urethral stricture tissue. J Urol 150(2 Pt 2):642–647
doi: 10.1016/S0022-5347(17)35572-6
Sergi F, Flammia GP, Alcini A, Perrone G, Guaglianone S, Forastiere E, Rabitti C, Gallucci M (2007) Collagen changes in the ureteropelvic junction after failed antegrade endopyelotomy. J Endourol 21(1):103–107. https://doi.org/10.1089/end.2006.9996
doi: 10.1089/end.2006.9996 pubmed: 17263620
Wolf JS Jr, Soble JJ, Ratliff TL, Clayman RV (1996) Ureteral cell cultures II: collagen production and response to pharmacologic agents. J Urol 156(6):2067–2072
doi: 10.1016/S0022-5347(01)65437-5
Acharya P, Beckel J, Ruiz WG, Wang E, Rojas R, Birder L, Apodaca G (2004) Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium. Am J Physiol Renal Physiol 287(2):F305-318. https://doi.org/10.1152/ajprenal.00341.2003
doi: 10.1152/ajprenal.00341.2003 pubmed: 15068973
Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277(5698):665–667
doi: 10.1038/277665a0
Will TA, Polcari AJ, Garcia JG, Ouwenga MK, Voelzke BB, Greisler HP, Turk TM (2011) Paclitaxel inhibits ureteral smooth muscle cell proliferation and collagen production in the absence of cell toxicity. J Urol 185(1):335–340. https://doi.org/10.1016/j.juro.2010.09.006
doi: 10.1016/j.juro.2010.09.006 pubmed: 21075396
Katsanos K, Spiliopoulos S, Paraskevopoulos I, Diamantopoulos A, Karnabatidis D (2016) Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the Femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther 23(2):356–370
doi: 10.1177/1526602815626557
Kitrou PM, Papadimatos P, Spiliopoulos S, Katsanos K, Christeas N, Brountzos E, Karnabatidis D (2017) Paclitaxel-coated balloons for the treatment of symptomatic central venous stenosis in dialysis access: results from a Randomized Controlled Trial. JVIR 28(6):811–817
doi: 10.1016/j.jvir.2017.03.007
Barbalias D, Lappas G, Ravazoula P, Liourdi D, Kyriazis I, Liatsikos E, Kallidonis P (2018) Evaluation of the distribution of paclitaxel after application of a paclitaxel-coated balloon in the rabbit urethra. J Endourol 32(5):381–386
doi: 10.1089/end.2017.0935
Liourdi D, Kallidonis P, Kyriazis I, Tsamandas A, Karnabatidis D, Kitrou P, Spyroulias GA, Kostopoulou ON, Marousis K, Kalpaxis DL, Goumenos DS, Liatsikos E (2015) Evaluation of the distribution of Paclitaxel by immunohistochemistry and nuclear magnetic resonance spectroscopy after the application of a drug-eluting balloon in the porcine ureter. J Endourol 29(5):580–589. https://doi.org/10.1089/end.2014.0683
doi: 10.1089/end.2014.0683 pubmed: 25441059
Khalilzadeh O, Baerlocher MO, Shyn PB, Connolly BL, Devane AM, Morris CS, Cohen AM, Midia M, Thornton RH, Gross K, Caplin DM, Aeron G, Misra S, Patel NH, Walker TG, Martinez-Salazar G, Silberzweig JE, Nikolic B (2017) Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. JVIR 28(10):1432-1437.e1433. https://doi.org/10.1016/j.jvir.2017.06.019
doi: 10.1016/j.jvir.2017.06.019 pubmed: 28757285
Hofer MD, Liu JS, Morey AF (2017) Treatment of Radiation-Induced Urethral Strictures. Urol Clinics N Am 44(1):87–92. https://doi.org/10.1016/j.ucl.2016.08.005
doi: 10.1016/j.ucl.2016.08.005
Lucas JW, Ghiraldi E, Ellis J, Friedlander JI (2018) Endoscopic management of ureteral strictures: an update. Curr Urol Rep 19(4):24. https://doi.org/10.1007/s11934-018-0773-4
doi: 10.1007/s11934-018-0773-4 pubmed: 29500521
DiMarco DS, LeRoy AJ, Thieling S, Bergstralh EJ, Segura JW (2001) Long-term results of treatment for ureteroenteric strictures. Urology 58(6):909–913. https://doi.org/10.1016/s0090-4295(01)01420-0
doi: 10.1016/s0090-4295(01)01420-0 pubmed: 11744456
Kwak S, Leef JA, Rosenblum JD (1995) Percutaneous balloon catheter dilatation of benign ureteral strictures: effect of multiple dilatation procedures on long-term patency. Am J Roentgenol 165(1):97–100. https://doi.org/10.2214/ajr.165.1.7785643
doi: 10.2214/ajr.165.1.7785643
Meretyk S, Clayman RV, Kavoussi LR, Kramolowsky EV, Picus DD (1991) Endourological treatment of ureteroenteric anastomotic strictures: long-term followup. J Urol 145(4):723–727. https://doi.org/10.1016/s0022-5347(17)38435-5
doi: 10.1016/s0022-5347(17)38435-5 pubmed: 2005687
van Son MJ, Lock M, Peters M, van de Putte EEF, Meijer RP (2019) Treating benign ureteroenteric strictures: 27-year experience comparing endourological techniques with open surgical approach. World J Urol 37(6):1217–1223. https://doi.org/10.1007/s00345-018-2475-4
doi: 10.1007/s00345-018-2475-4 pubmed: 30232554
Aytekin C, Boyvat F, Harman A, Ozyer U, Colak T, Haberal M (2007) Percutaneous therapy of ureteral obstructions and leak after renal transplantation: long-term results. Cardiovasc Intervent Radiol 30(6):1178–1184. https://doi.org/10.1007/s00270-007-9031-8
doi: 10.1007/s00270-007-9031-8 pubmed: 17508243
Kaskarelis I, Koukoulaki M, Georgantas T, Bairamidis E, Kokkinos C, Ieronymou M, Vougas V, Drakopoulos S (2008) Ureteral complications in renal transplant recipients successfully treated with interventional radiology. Transpl Proc 40(9):3170–3172. https://doi.org/10.1016/j.transproceed.2008.08.040
doi: 10.1016/j.transproceed.2008.08.040
Pappas P, Giannopoulos A, Stravodimos KG, Zavos G, Alexopoulos T, Boletis J, Tzortzis G, Kostakis A (2001) Obstructive uropathy in the transplanted kidney: definitive management with percutaneous nephrostomy and prolonged ureteral stenting. J Endourol 15(7):719–723. https://doi.org/10.1089/08927790152596316
doi: 10.1089/08927790152596316 pubmed: 11697404
Reus C, Brehmer M (2019) Minimally invasive management of ureteral strictures: a 5-year retrospective study. World J Urol 37(8):1733–1738. https://doi.org/10.1007/s00345-018-2539-5
doi: 10.1007/s00345-018-2539-5 pubmed: 30377811
Diamantopoulos A, Gupta Y, Zayed H, Katsanos K (2015) Paclitaxel-coated balloons and aneurysm formation in peripheral vessels. J Vasc Surg 62(5):1320–1322. https://doi.org/10.1016/j.jvs.2014.03.291
doi: 10.1016/j.jvs.2014.03.291 pubmed: 24801552

Auteurs

Panagiotis Kallidonis (P)

Department of Urology, University of Patras, Patras, Greece. pkallidonis@yahoo.com.

Stavros Spiliopoulos (S)

2nd Department of Radiology, National and Kapodistrian University of Athens, Athens, Greece.

Panagiotis Papadimatos (P)

Department of Interventional Radiology, University of Patras, Patras, Greece.

Constantinos Katsanos (C)

Department of Interventional Radiology, University of Patras, Patras, Greece.

Despoina Liourdi (D)

Department of Urology, University of Patras, Patras, Greece.

Arman Tsaturyan (A)

Department of Urology, University of Patras, Patras, Greece.

Dimitrios Karnabatidis (D)

Department of Interventional Radiology, University of Patras, Patras, Greece.

Evangelos Liatsikos (E)

Department of Urology, University of Patras, Patras, Greece.
Department of Urology, Medical University of Vienna, Vienna, Austria.
Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Panagiotis Kitrou (P)

Department of Interventional Radiology, University of Patras, Patras, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH